Although analysis from ccRCC tumor lysates revealed that increased AMPK mRNA and pAMPK are associated with favorable outcomes [1,6], the prognostic significance of pAMPK subcellular location has not yet been investigated in patients with ccRCC. The gene discussed is PRKAA1; the disease is neoplasm.